{"title":"光可转换铱(III)基光敏剂:在肿瘤治疗中实现非侵入性、可逆 ROS 控制的双态系统","authors":"Zhi-Tong Chu, Na Xu, Yan Su, Hongbao Fang, Zhi Su","doi":"10.1039/d4dt02673j","DOIUrl":null,"url":null,"abstract":"Photodynamic therapy (PDT), a powerful anticancer approach converting oxygen to ROS for tumor ablation, encounters hurdles like limited spatio-temporal selectivity, and the consequent unnecessary damage to normal tissues. Addressing these challenges, developing controllable Ir(III)-based photosensitizers (PSs) emerges as a promising solution, offering enhanced efficacy and precision in cancer therapy, while propelling the clinical progression of metal-based PSs. Herein, we proposed a series of light-controlled PSs, integrating Ir(III)-based moiety with a light-responsive module, enabling non-invasive \"off-on\" control of ROS production via efficient energy transfer. The open form (OF) in this dual-state system has better lipid solubility and cellular uptake compared to the closed form (CF), which facilitates targeted delivery of metal drugs. Comprehensive intracellular experiments demonstrated the OF complex's superior cytotoxicity under light irradiation, with the CF complex achieving comparable toxicity post-conversion. Notably, the PSs inhibited 3D tumor growth and modulated intracellular ROS production. These findings underscore the potential of Ir(III)-based dual-state photoswitchable complexes as a platform for non-invasive, reversible ROS control, offering broad prospects in tumor therapy and beyond.","PeriodicalId":71,"journal":{"name":"Dalton Transactions","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Light Switchable Ir(III)-Based Photosensitizers: A Dual-State System for Non-Invasive, Reversible ROS Control in Tumor Therapy\",\"authors\":\"Zhi-Tong Chu, Na Xu, Yan Su, Hongbao Fang, Zhi Su\",\"doi\":\"10.1039/d4dt02673j\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Photodynamic therapy (PDT), a powerful anticancer approach converting oxygen to ROS for tumor ablation, encounters hurdles like limited spatio-temporal selectivity, and the consequent unnecessary damage to normal tissues. Addressing these challenges, developing controllable Ir(III)-based photosensitizers (PSs) emerges as a promising solution, offering enhanced efficacy and precision in cancer therapy, while propelling the clinical progression of metal-based PSs. Herein, we proposed a series of light-controlled PSs, integrating Ir(III)-based moiety with a light-responsive module, enabling non-invasive \\\"off-on\\\" control of ROS production via efficient energy transfer. The open form (OF) in this dual-state system has better lipid solubility and cellular uptake compared to the closed form (CF), which facilitates targeted delivery of metal drugs. Comprehensive intracellular experiments demonstrated the OF complex's superior cytotoxicity under light irradiation, with the CF complex achieving comparable toxicity post-conversion. Notably, the PSs inhibited 3D tumor growth and modulated intracellular ROS production. These findings underscore the potential of Ir(III)-based dual-state photoswitchable complexes as a platform for non-invasive, reversible ROS control, offering broad prospects in tumor therapy and beyond.\",\"PeriodicalId\":71,\"journal\":{\"name\":\"Dalton Transactions\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-10-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dalton Transactions\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://doi.org/10.1039/d4dt02673j\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, INORGANIC & NUCLEAR\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dalton Transactions","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1039/d4dt02673j","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
Light Switchable Ir(III)-Based Photosensitizers: A Dual-State System for Non-Invasive, Reversible ROS Control in Tumor Therapy
Photodynamic therapy (PDT), a powerful anticancer approach converting oxygen to ROS for tumor ablation, encounters hurdles like limited spatio-temporal selectivity, and the consequent unnecessary damage to normal tissues. Addressing these challenges, developing controllable Ir(III)-based photosensitizers (PSs) emerges as a promising solution, offering enhanced efficacy and precision in cancer therapy, while propelling the clinical progression of metal-based PSs. Herein, we proposed a series of light-controlled PSs, integrating Ir(III)-based moiety with a light-responsive module, enabling non-invasive "off-on" control of ROS production via efficient energy transfer. The open form (OF) in this dual-state system has better lipid solubility and cellular uptake compared to the closed form (CF), which facilitates targeted delivery of metal drugs. Comprehensive intracellular experiments demonstrated the OF complex's superior cytotoxicity under light irradiation, with the CF complex achieving comparable toxicity post-conversion. Notably, the PSs inhibited 3D tumor growth and modulated intracellular ROS production. These findings underscore the potential of Ir(III)-based dual-state photoswitchable complexes as a platform for non-invasive, reversible ROS control, offering broad prospects in tumor therapy and beyond.
期刊介绍:
Dalton Transactions is a journal for all areas of inorganic chemistry, which encompasses the organometallic, bioinorganic and materials chemistry of the elements, with applications including synthesis, catalysis, energy conversion/storage, electrical devices and medicine. Dalton Transactions welcomes high-quality, original submissions in all of these areas and more, where the advancement of knowledge in inorganic chemistry is significant.